Home | Volume 36 | Article number 180

Research

Prevalence of onchocerciasis after seven years of continuous community-directed treatment with ivermectin in the Ntui health district, Centre region, Cameroon

Prevalence of onchocerciasis after seven years of continuous community-directed treatment with ivermectin in the Ntui health district, Centre region, Cameroon

Estelle Makou Tsapi1, Françoise Guemgne Todjom2, Guy-Armand Gamago3, Josué Wabo Pone3, Félicité Flore Djuikwo Teukeng3,&

 

1Evangelical University of Cameroon, Bandjoun, Cameroon, 2Research Unit of Biology and Applied Ecology, Faculty of Science, University of Dschang, Dschang, Cameroon, 3Faculté des Sciences de la Santé, Université des Montagnes, Bangangté, Cameroon

 

 

&Corresponding author
Félicité Flore Djuikwo Teukeng, Faculté des Sciences de la Santé, Université des Montagnes, Bangangté, Cameroon

 

 

Abstract

Introduction: onchocerciasis is one of the major infectious diseases caused by Onchocerca volvulus. This parasite is responsible for chronic cutaneous and ocular diseases affecting more than 37 million people of whom 99% are in Africa. The study was conducted in the health district of Ntui from June to September 2016 to determine the prevalence of O. volvulus infection after seven years of massive administration of ivermectin.

 

Methods: two cutaneous snips were made at the iliac crests level in volunteers. These tissues were incubated in physiological saline water and were examined for parasitological investigations in the laboratory.

 

Results: a total of 310 participants were randomly selected, of whom 170 (54.8%) were women and 140 (45.1%) were men aged 6 to 83 years, thus giving a sex ratio of 1.2 in favour of women. After parasitological analysis, 26 participants had microfilaraemia, of whom 15 (10.7%) were men and 11 (6.4%) were women. The most infected age group was 16 to 26 years (12.5%). The highest infection rates were found among farmers (11%) and participants living in the village of Essougly (26.6%). No significant differences in prevalence values between the different groups were noted, whatever the parameter considered.

 

Conclusion: the prevalence of onchocerciasis in the health district of Ntui has declined from a hyperendemic to a hypoendemic state after seven years of massive administration of ivermectin. However, careful monitoring of onchocerciasis should be continued to prevent the area from returning to its original hyperendemicity.

 

 

Introduction    Down

Onchocerciasis is a neglected tropical disease of the skin and eyes caused by the filarial nematode Onchocerca volvulus, which lives in the lymphatic and subcutaneous spaces of humans. It is transmitted by the bites of infected black flies belonging to the genus Simulium. In the world, it is the second infection that causes blindness. Onchocerciasis is also responsible for skin disease such as unsightly skin lesions, debilitating itching and excess mortality among highly infected people. It is also a major risk factor for epilepsy and nodding syndrome [1,2]. Because of its negative impact on health, this public health problem was important in tropical Africa, Latin America and Yemen with more than 40 million people infected before the launch of large-scale control and an at-risk population of more than 160 million of which more than 99% live in Africa [3,4]. In 1987, the use of a safe anthelminthic: ivermectin (Mectizan™) has radically changed the fight against onchocerciasis. Ivermectin administration at regular intervals has, in the long term, interrupted transmission of new infections with O. volvulus in endemic foci [5,6].

 

Mass drug administration (MDA) campaigns repeatedly conducted through control programs have eliminated the disease in four Latin American countries between 2013 and 2016, namely Colombia, Ecuador, Guatemala and Mexico [7,8]. In 1995, at the launch of the African Program for Onchocerciasis Control (APOC), 37 million people were assumed to be infected. This program was launched with the main objective of controlling onchocerciasis as a public health problem in those African countries which were not covered by the Organization for the Prevention of Blindness (“Organisation pour la Prévention de la Cécité”) and supported more than 80% of the global burden of onchocercal disease [4]. This led to a significant improvement in the coverage of MDA treatment. After 30 years of MDA with Mectizan™, onchocerciasis transmission was interrupted in some African foci by massive administration of ivermectin once or twice a year. The feasibility of eliminating onchocerciasis through long-term mass treatment with ivermectin in Africa has been demonstrated in Mali and Senegal [5,9]. In Cameroon, a significant reduction in the prevalence of infection in children and adults after 5 to 13 years of annual community treatment with ivermectin has been demonstrated [10].

 

However, onchocerciasis remains a major concern in several endemic zones [11], with prevalence values above 60% in the centre, littoral and west in 2011 [12]. Indeed, 62% of rural people living in these endemic areas are threatened, i.e. about 9 million Cameroonians of whom 5 million are infected by worms and 30,000 blind [13]. In 2009, the prevalence of onchocerciasis in the forest-savanna transition zone in the Ntui health district was 26.3% [14]. Although there is some evidence to suggest that the disease is about to be eradicated in several districts of Cameroon [15], extensive epidemiological and entomological investigations are still needed to assess the disease situation in order to detect infection in human population and vector insect samples. The objective of the present survey was therefore: to determine the prevalence of O. volvulus in the Ntui health district after seven years of Continuous Community-Directed Treatment Intervention (CDTI) with ivermectin and; to assess whether treatment with ivermectin should be continued at the same or different periodicity depending on the prevalence in people and black flies.

 

 

Methods Up    Down

Study area: this study was designed as a cross-sectional prevalence study and was conducted from June to September 2016 among residents of Ntui, a Cameroonian town located in the Centre region. Ntui is also the main town of the Mbam and Kim division. This city is located in the equatorial zone (42°27'00" N, 11°38'00" E). The relief is marked by the presence of plains, hills, valleys and slopes. The climate is subequatorial with a tropical tendency: it is characterized by a long dry season from mid-November to the end of March, a short rainy season from mid-March to mid-May, a short dry season from mid-June to mid-July and a long rainy season from mid-August to mid-November [16]. The average annual temperature in this zone is 26°C, with a maximum reaching 37°C in January [16]. The hydrographic network includes the Sanaga river and four tributaries: Meloko, Mpiem, Obagne and Ossombo. The main activity of population is agriculture. A previous survey in this area showed a high prevalence of onchocerciasis: 26.3% in 2009 [14]. Since that date, no investigation has been conducted despite an annual mass drug administration with ivermectin in that locality.

 

Selection of participants: this study was carried out at the Ntui District Hospital. Eleven health areas and 30 functional sanitary facilities (18 public and 12 private) are present in this district [17]. The minimum sample size was estimated using the report by Naing et al. [18] according to the formula.

Where N, minimum sample size; Z, standard value; P, expected prevalence of onchocerciasis in the study area; d, precision of error at 5% with a 95% confidence interval. As Z=1.96, P=26.3% (the prevalence in the area in 2009) and d=5%, N=298. Each participant received a pre-tested questionnaire and was also interviewed about his socio-demographic, clinical and parasitological data. His (or her) name, age, sex, home and occupation were recorded. Information was also provided on the symptoms of onchocerciasis. During the interview, the children were asked in their mother language (“mbulu”) to ensure the reliability of the information.

 

Protocol of investigations: a total of 310 people were enrolled in the study. In each village, the first task was to sensitize the whole population. The symptoms noted during the interrogation were pruritus (skin and eyes), filarial scabies, depigmentation of the skin, lacrimation, blurred vision, decreased visual field and/or gene in the light. After the population census, two biopsies were performed on each participant, one at the left iliac crest and the other at the right iliac crest. Each area to be biopsied was disinfected with 70% alcohol and the skin was lifted (approximately 1 to 2mm) with a needle to collect a small piece of skin with a razor blade. Each skin fragment was then placed in a coded tube containing physiological saline water and left at outdoor temperature. Samples collected from a household were sent to the hospital laboratory prior to visit the next household. The fresh preparation was left to stand and was analyzed after 30 min and after 24h under a light microscope at low magnification (10x and 40x) to detect microfilariae. Individuals with biopsies containing microfilariae after 30 min were considered infected with O. volvulus.

 

Parameters studied and statistical analysis: the overall prevalence of O. volvulus infection was expressed in relation to the age of participants (from 6 to more than 46 years), their sex, their occupation and the village in which they lived along the Sanaga river. The collected data were entered into Microsoft Excel 2013 and imported into the SPSS 20.0 software. Prevalence values were compared using the chi-squared test. The differences were considered significant at p<0.05.

 

Ethical considerations: the protocol in this study was approved by the Institutional Ethics Committee of the Evangelical University Institute of Cameroon (IUEC).

 

 

Results Up    Down

A total of 310 participants were randomly selected. Of the 310 samples collected, 26 (8.3%) were infected with O. volvulus. The prevalence of infection was 10.7% (15/140) in boys and men, while it was 6.4% (11/170) in girls and women. The 16-26 year group (Table 1) was the most infected (12.5%). A gradual decrease in the prevalence was noted in the other age groups: 26-36 yrs (11.2%), > 46 yrs (8%), 36-46 yrs (7.6%) and 6-16 yrs (2.2%). In the population studied (Table 2), the infection was high among farmers (10.7%), followed by housewives (8.6%) and schoolchildren (2.2%). No significant difference between the prevalence values was noted, whatever the factor studied. The prevalence of infection in relation to the housing of participants is given in Table 3. Participants from the Essougly village were the most infected (26.6%), followed by those from Kela (23.5%), Ndowe (15.7%), Nachtigal (13.3%) and Nkolve (11.7%). In each of the following villages: Ehondo, Kake, Mbandona, Mbanga, Nkouloutou and Onguesse, the prevalence of infection was less than 10%. No infected patient was noted in the other three villages. No significant difference between the infection rates recorded in the 11 villages was noted.

 

 

Discussion Up    Down

The objective of the present survey was to assess the prevalence of O. volvulus in the district of Ntui after seven years of Continuous Community-Directed Treatment Intervention (CDTI) with ivermectin. Our results show an overall prevalence of 8.3%. The prevalence of onchocerciasis in the study area is low, despite the presence of several fast-flowing rivers, black flies and an atmosphere favouring the interaction between farmers and biting flies. This result may be attributed to distribution of ivermectin for even years to eradicate onchocerciasis in this study area. Indeed, annual or semi-annual ivermectin treatments of populations in onchocerciasis endemic areas have proved to be an effective strategy for controlling the disease [19]. This low prevalence is similar to that (7.5%) reported by Katabarwa et al. in Uganda [20], but is lower than those reported by Same Ekobo et al. (13.2%) during the construction of the Lom Pangar dam in East Cameroon [21], by Kueté et al. (26.3%) in the central region of Cameroon [14] or by Osue et al. (37.9%) in Nigeria [22]. The difference observed in these studies can be due to the fact that populations have more or less taken the annual Mectizan™ treatment.

 

Compared to women, men were more infected in the present study (10.7% versus 6.4%). Similar results were reported by Wogu and Okaka [23] in the town of Okpujeau in Nigeria (27.5% for men and 20% for women) and by Kamga et al. [24] in the Fundong health district in north-west Cameroon (2% for men and 1.5% for women). The fact that men are more infected than women can be justified by their daily activities. Although women and men are engaged in the same field works, men during their activity are less likely to cover their body, which exposes them more to black fly bites since these flies have diurnal activities [25]. In the present study, the most infected age group with O. volvulus was 16 to 26 years with a prevalence of 12.5%, whereas the least infected (2.2%) was aged 6 to 16 years. These results are different from those reported by Uttah (2010) in the Imo river watershed in Nigeria [26]. According to this author, people aged 60 years and more were the most infected (70.4%), while the least infected (13.9%) concerned patients aged 20 to 39 years [26]. The difference between these two studies could be explained by the fact that people of 16 to 26 years were the single persons which worked the most in the plantations of the Ntui locality.

 

Farmers (10.7%) were more infected, followed by housewives (8.6%) and schoolchildren (2.2%). These observations are similar to those found by Wandji et al. in the Konye, Mamfe, Eyumojok and Kumbadans districts of south-west Cameroon [27]. In fact, black flies did not enter the houses, but stung outside during the day along the river banks [28]. Most infected participants (26.6%) came from the Essougly village, followed by those of Kela, Ndowe, Nachtigal, Nkolve, Nkouloutou, Mbanga and Ehondo (23.5%, 15.7% 13.3%, 11.7%, 9.5%, 9% and 7.1%). All these villages are located less than 10km from the Nachtigal waterfalls and are hyperendemic for onchocerciasis because the distance between their village and this river was negatively correlated with the prevalence of O. volvulus infection and the black flies did not fly more than 6km [29]. This high prevalence could be explained by the fact that the population of the Essougly village was more present in the cocoa plantations, which are very close to the Sanaga river, as well as by its high vegetation.

 

 

Conclusion Up    Down

The overall prevalence of human infections by O. volvulus (8.3%) in the district of Ntui has considerably decreased over time. Similarly, the male sex, the age group 16-26 years and farmers were the most infected. The massive administration of ivermectin during seven successive years thus reduced the transmission of the disease. Consequently, the prevalence of O. volvulus infection in this health district has decreased from a hyperendemic to a hypoendemic state. However, careful monitoring of onchocerciasis should be continued to prevent the area from returning to its original hyperendemicity.

What is known about this topic

  • In Cameroon, a significant reduction in the prevalence of infection in children and adults after 5 to 13 years of annual community treatment with ivermectin has been demonstrated since 2003;
  • Onchocerciasis remains a major concern in several endemic zones, with prevalence values above 60% in the centre, littoral and west in 2011.

What this study adds

  • The massive administration of ivermectin during seven successive years has reduced the transmission of the disease;
  • The prevalence of onchocerciasis in the health district of Ntui has declined from a hyperendemic to a hypoendemic state.

 

 

Competing interests Up    Down

The authors declare no competing interests.

 

 

Authors' contributions Up    Down

FF Djuikwo Teukeng elaborated the concept design and drafted the manuscript; E Makou Tsapi was involved in patient recruitment and biological examination; F Guemgne Todjom and GA Gamago contributed to blood and skin examination; J Wabo Pone critically revised the article. All the authors have read and agreed to the final manuscript.

 

 

Acknowledgments Up    Down

The authors thank the people of Ntui for their cooperation and assistance in the data collection and the staff members of the Ntui District Hospital for their collaboration in laboratory investigations.

 

 

Tables Up    Down

Table 1: prevalence of Onchocerca volvulus infection in the 310 samples in relation to the age of participants

Table 2: prevalence of Onchocerca volvulus infection in relation to the occupation of participants

Table 3: prevalence of Onchocerca volvulus infection in relation to the village where the participants lived

 

 

References Up    Down

  1. Murdoch ME, Asuzu MC, Hagan M, Makunde WH, Ngoumou P, Ogbuagu KF et al. Onchocerciasis: the clinical and epidemiological burden of skin disease in Africa. Ann Trop Med Parasitol. 2002;96(3):283-296. PubMed | Google Scholar

  2. Korevaar DA, Visser BJ. Reviewing the evidence on nodding syndrome, a mysterious tropical disorder. Int J Infect Dis. 2013;17(3):e149-e52. PubMed | Google Scholar

  3. World Health Organization. Onchocerciasis and its control: report of a WHO expert committee on onchocerciasis control. World Health Organ Tech Rep Ser. 1995. PubMed | Google Scholar

  4. O'Hanlon SJ, Slater HC, Cheke RA, Boatin BA, Coffeng LE, Pion SD et al. Model-based geostatistical mapping of the prevalence of Onchocerca volvulus in West Africa. PLoS Negl Trop Dis. 2016;10(1):e0004328. PubMed | Google Scholar

  5. Diawara L, Traore MO, Badji A, Bissan Y, Doumbia K, Goita SF et al. Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal. PLoS Negl Trop Dis. 2009;3(7):e497. PubMed | Google Scholar

  6. Tekle AH, Elhassan E, Isiyaku S, Amazigo UV, Bush S, Noma M et al. Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African programme for onchocerciasis control. Parasit Vectors. 2012;5:28. PubMed | Google Scholar

  7. World Health Organization. Progress towards eliminating onchocerciasis in the WHO region of the Americas: verification by WHO of elimination of transmission in Colombia. Wkly Epidemiol Rec. 2013;88(36):381-385. PubMed | Google Scholar

  8. Rodríguez-Atanacio JA, Domínguez-Vázquez A, Rodríguez-Morales KB, Real-Najarro O, Prado-Velasco FG, Cupp EW et al. Elimination of onchocerciasis from Mexico. PLoS Negl Trop Dis. 2015;9(7):e0003922. PubMed | Google Scholar

  9. Traore MO, Sarr MD, Badji A, Bissan Y, Diawara L, Doumbia K et al. Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal. PLoS Negl Trop Dis. 2012;6(9):e1825. PubMed | Google Scholar

  10. Wanji S, Winston P, Chounna N, Fri Fombad F, Kengne-Ouafo JA, Njouendou AJ et al. Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa. PLoS Negl Trop Dis. 2018;12(9):e0006750. PubMed | Google Scholar

  11. World Health Organization. African programme for onchocerciasis control: report of the sixth meeting of national task forces, October 2009. Wkly Epidemiol Rec. 2010;85(4):23-28. PubMed | Google Scholar

  12. Tekle AH, Zoure HG, Noma M, Boussinesq M, Coffeng LE, Stolk WA et al. Progress towards onchocerciasis elimination in the participating countries of the African programme for onchocerciasis control: epidemiological evaluation results. Infect Dis Poverty. 2016;5(1):66. PubMed | Google Scholar

  13. Tanya VN, Wanji S, Kamgno J, Achukwi DM, Enyong PAI. Recent advances in onchocerciasis research and implications for control. Yaoundé: The Cameroon Academy of Sciences. 2012.

  14. Kuete T, Mbuagbaw J, Kollo B, Kitobo E, Same-Ekobo A. Distribution des filarioses dans une zone de transition savane-forêt du Cameroun, impact sur la prise en charge: cas de l'Aire de santé de Ntui, Département du Mbam et Kim. J Cameroon Acad Sci. 2009;8(1):11-16. Google Scholar

  15. Kamga GR, Dissak-Delon FN, Nana-Djeunga HC, Biholong BD, Mbigha Ghogomu S, Souopgui J et al. Important progress towards elimination of onchocerciasis in the West Region of Cameroon. Parasit Vectors. 2017;10(1):373. PubMed | Google Scholar

  16. Communes et Villes Unies du Cameroun (CVUC). Ntui. Accessed 2016 May 26.

  17. Dispensaire de Ntui (DSN). Présentation du district de santé de Ntui. Ntui Health District (mimeographed document). 2015.

  18. Naing L, Winn T, Rusli BN. Practical issues in calculating the sample size for prevalence studies. Arch Orofac Sci. 2006;1:9-14. Google Scholar

  19. Tekle AH, Zoure H, Wanji S, Leak S, Noma M, Remme JH et al. Integrated rapid mapping of onchocerciasis and loiasis in the Democratic Republic of Congo: impact on control strategies. Acta Trop. 2011;120(Suppl 1):S81-S90. PubMed | Google Scholar

  20. Katabarwa MN, Lakwo T, Habumugisha P, Unnasch TR, Garms R, Hudson-Davis L et al. After 70 years of fighting an age-old scourge, onchocerciasis in Uganda, the end is in sight. Int Health. 2018;10(Suppl 1):i79-i88. PubMed | Google Scholar

  21. Samé Ekobo A, Pradelles Y, Adeline T. Etude environnementale du barrage de Lom Pangar: impact sur la santé. Rapport final. octobre 2005.

  22. Osue HO, Inabo HI, Yakubu SE, Audu PA, Galadima M, Odama LE et al. Impact of eighteen-year varied compliance to onchocerciasis treatment with ivermectin in sentinel Savannah agrarian communities in Kaduna State of Nigeria. Int Sch Res Not: Parasitol. 2013;2013:960168. PubMed | Google Scholar

  23. Wogu MD, Okaka CE. Prevalence and socio-economic effects of onchocerciasis in Okpuje, Owan West local government area, Edo State, Nigeria. Int J Biomed Health Sci. 2008;4(3):113-119.

  24. Fouamno Kamga HL, Nsagha Shey D, Nguedia Assob JC, Longdoh Njunda A, Nde Fon P, Kindong Njem P. Prevalence of onchocerciasis in the Fundong Health District, Cameroon after 6 years of continuous community-directed treatment with ivermectin. Pan African Medical Journal. 2011;10:34. PubMed | Google Scholar

  25. Gentilini M, Lenoble R. Filarioses. Médecine Tropicale. Paris Lavoisier. 2012;6.

  26. Uttah EC. Onchocerciasis in the upper Imo river basin, Nigeria: prevalence and comparative study of waist and shoulder snips from mesoendemic communities. Iran J Parasitol. 2010;5(2):33-41. PubMed | Google Scholar

  27. Wanji S, Kengne-Ouafo JA, Esum MA, Chounna PWN, Adzemye BF, Eyong JEE, Jato I et al. Relationship between oral declaration on adherence to ivermectin treatment and parasitological indicators of onchocerciasis in an area of persistent transmission despite a decade of mass drug administration in Cameroon. Parasit Vectors. 2015;8:667. PubMed | Google Scholar

  28. Hopkins A, Boatin BA. Onchocerciasis: in: JMH Selendy, Water and sanitation-related diseases and the environment: challenges, interventions, and preventive measures. London. Wiley-Blackwell. 2011;113-149. Google Scholar

  29. Lepori AS. L´onchocercose: données actuelles et nouvel horizon thérapeutique: le rôle de la doxycycline dans le traitement de l'onchocercose. University of Nancy: Pharm D thesis. 2013. Google Scholar